To confirm that the recruitment of PTEN and Csk to the sequence of Cx43 containing residues 266–283 is sufficient to inhibit c-Src and its downstream pathway, we tested the effect of the peptide TAT-Cx43-266-283 on G166 human glioblastoma stem cells (GSCs) [38]. Here, SRC is linked to glioblastoma.